Legal & General Group’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Legal & General Group's GOSS Position: Q2 2026 in Review
Legal & General Group sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 17,298 shares — an estimated $5.68K sold.
Legal & General Group first reported a position in GOSS in Q1 2019 and held it in 21 quarters. The position peaked at $251K in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Legal & General Group reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
- Legal & General Group sold 17,298 Gossamer Bio shares in Q2 2026, an estimated $5.68K.
- Legal & General Group first reported a position in Gossamer Bio in Q1 2019 and held it in 21 quarters.
- Legal & General Group's Gossamer Bio position peaked at $251K in Q3 2022.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.